- Report
- September 2026
- 185 Pages
Global
From €3328EUR$3,545USD£2,777GBP
€3698EUR$3,939USD£3,085GBP
- Report
- September 2026
- 194 Pages
Global
From €3328EUR$3,545USD£2,777GBP
€3698EUR$3,939USD£3,085GBP
- Report
- February 2026
- 250 Pages
Global
From €4216EUR$4,490USD£3,517GBP
- Report
- July 2026
- 200 Pages
Global
From €7502EUR$7,990USD£6,259GBP
- Report
- January 2026
- 280 Pages
Global
From €2817EUR$3,000USD£2,350GBP
- Report
- May 2026
- 150 Pages
Global
From €2619EUR$2,789USD£2,185GBP
- Report
- May 2026
- 100 Pages
Global
From €2534EUR$2,699USD£2,114GBP
- Report
- May 2024
- 131 Pages
Global
From €3755EUR$3,999USD£3,132GBP
- Report
- May 2024
- 132 Pages
Global
From €3755EUR$3,999USD£3,132GBP
- Report
- October 2023
- 145 Pages
Global
From €2958EUR$3,150USD£2,467GBP
- Report
- August 2024
- 80 Pages
Japan
From €3286EUR$3,500USD£2,742GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2817EUR$3,000USD£2,350GBP
- Report
- May 2024
- 132 Pages
Global
From €3755EUR$3,999USD£3,132GBP
- Report
- February 2024
- 360 Pages
Global
From €7464EUR$7,950USD£6,227GBP
- Report
- December 2023
- 140 Pages
Global
From €4178EUR$4,450USD£3,486GBP
- Report
- April 2025
- 137 Pages
Asia Pacific
From €3239EUR$3,450USD£2,702GBP
- Report
- April 2025
- 136 Pages
Middle East, Africa
From €3239EUR$3,450USD£2,702GBP
- Report
- July 2024
- 150 Pages
Global
From €4178EUR$4,450USD£3,486GBP
- Report
- November 2020
- 199 Pages
Global
€4225EUR$4,500USD£3,525GBP
- Report
- November 2026
- 50 Pages
Global
From €2488EUR$2,650USD£2,076GBP

Bimatoprost is a medication used to treat glaucoma and other optical disorders. It is a prostaglandin analog, meaning it works by increasing the outflow of fluid from the eye, reducing intraocular pressure. Bimatoprost is available as a topical ophthalmic solution, and is the only prostaglandin analog approved for the treatment of glaucoma and ocular hypertension. It is also used to treat hypotrichosis, a condition characterized by inadequate or thinning eyelashes.
Bimatoprost is a widely used medication in the optical disorders drugs market. It is the most commonly prescribed prostaglandin analog for glaucoma and ocular hypertension, and is also used off-label for other conditions. Bimatoprost is generally well-tolerated, with few side effects.
Some companies in the Bimatoprost market include Allergan, Sun Pharmaceuticals, and Pfizer. Show Less Read more